House Committee on Public Health - 76th R.S. (1999)
- Review the role of the pharmaceutical industry in the delivery of health care in Texas. The review should identify pharmaceutical cost-drivers and opportunities to reduce costs, assess the role of pharmacy benefit managers and pharmacies, and address patient-specific issues, as well as other issues identified by the committee.
- Review issues related to the increased use of new technologies in the delivery of health care. The review should identify opportunities and risks associated with the sale of medical devices and drugs over the Internet, the feasibility of expanding telemedicine to improve care in underserved areas, and regulatory and privacy issues presented by these new technologies.
- Evaluate the role and potential of disease management in public health programs that serve chronically ill populations.
- Study issues arising from hospital system sales, conversions, partnerships and mergers, including the impact on health care in medically underserved and rural communities and on the level of charity care provided.
- Examine the requirements imposed on emergency medical services providers in rural areas. Determine whether individual requirements encourage or hinder the provision of services.
- Conduct active oversight of the agencies under the committee's jurisdiction, including the Children's Health Insurance Program, the restructuring of health and humans service agencies under HB 2641 76th R.S., and the Medicaid managed care program.
Information on this website is provided as a public service by the Legislative Reference Library. The Legislative Reference Library makes no representation as to its completeness or accuracy and makes no warranty in regard to its use. Users assume all risk of reliance on the information included on this site.